Showing results (951-960 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|February 9, 2017
Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitusBin Yang, Can-Ze Huang, Tao Yu, et al.
Anti-Cancer Drugs|January 31, 2017
Chemotherapy for localized head and neck squamous cell cancersAndy Karabajakian, Philippe Toussaint, Eve-Marie Neidhardt, et al.
Anti-Cancer Drugs|February 7, 2017
Chemotherapy for recurrent/metastatic head and neck cancersAndy Karabajakian, Philippe Toussaint, Eve-Marie Neidhardt, et al.
Anti-Cancer Drugs|January 27, 2017
PI3K-δ inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cellsAva Safaroghli-Azar, Davood Bashash, Parisa Sadreazami, et al.
Anti-Cancer Drugs|December 1, 1991
Emerging differences between 5-HT3 receptor antagonistsH E Marr, P T Davey, A J Bartlett
Anti-Cancer Drugs|December 1, 1991
Enhanced anti-cancer effects of intralymphatic aclarubicin on distal lymph node metastases: quantitative evaluation using a new experimental model in miceA Hagiwara, T Takahashi, K Sawai, et al.
Anti-Cancer Drugs|December 1, 1991
Double-blind randomized cross-over trial comparing methylprednisolone with placebo in chemotherapy-induced nausea and vomiting: a study with special reference to efficacy parametersH Havsteen, M Kjaer
Anti-Cancer Drugs|March 8, 2006
Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cellsShunji Aoki, Seok-hwan Cho, Mayumi Ono, et al.
Anti-Cancer Drugs|March 8, 2006
Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cellsJin-Long Li, Yu-Chen Cai, Xu-Hui Liu, et al.
Anti-Cancer Drugs|November 29, 2007
Alterations in vascular architecture and permeability following OXi4503 treatmentLie Sam Chan, Cathy Malcontenti-Wilson, Vijayaragavan Muralidharan, et al.
Pageof 464